NeuroVive's objective is to design pharmaceuticals that preserve the integrity and function of mitochondria for indications where there is a great unmet medical need. NeuroVive is continuously engaged in the vibrant mitochondrial science community as well as the world of investors and potential partners.
Aktiespararna's Aktiedagen Lund, 28 January 2020, Lund, Sweden.
Aktiespararna's Stora Aktiedagen, 25 November 2019, Stockholm, Sweden.
Redeye Life Science Day, 19 November 2019, Stockholm, Sweden
BioStock Life Science Summit, 23 October 2019, Lund, Sweden.
NeuroVive Capital Markets Day, 9 October, 2019, Stockholm, Sweden.
Mitochondria Day, 18 September 2019, Stockholm, Sweden
Stockholm Corporate Finance 11th Life Science seminar, 13 – 14 March 2019.
Aktiedagen Lund 2019, 29 January